BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34326151)

  • 41. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors and outcomes of limited resection for early-stage non-small cell lung cancer.
    Billmeier SE; Ayanian JZ; Zaslavsky AM; Nerenz DR; Jaklitsch MT; Rogers SO
    J Natl Cancer Inst; 2011 Nov; 103(21):1621-9. PubMed ID: 21960708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical and survival outcomes of lung cancer patients with intratumoral lung abscesses.
    Yamanashi K; Okumura N; Takahashi A; Nakashima T; Matsuoka T
    J Cardiothorac Surg; 2017 May; 12(1):44. PubMed ID: 28549477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study protocol for VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a UK multicentre randomised controlled trial with an internal pilot (the VIOLET study).
    Lim E; Batchelor T; Shackcloth M; Dunning J; McGonigle N; Brush T; Dabner L; Harris R; Mckeon HE; Paramasivan S; Elliott D; Stokes EA; Wordsworth S; Blazeby J; Rogers CA;
    BMJ Open; 2019 Oct; 9(10):e029507. PubMed ID: 31615795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Second primary lung cancer and relapse: treatment and follow-up.
    Angeletti CA; Mussi A; Janni A; Lucchi M; Ribechini A; Chella A; Fontanini G
    Eur J Cardiothorac Surg; 1995; 9(11):607-11. PubMed ID: 8751247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial.
    Balekian AA; Wisnivesky JP; Gould MK
    Chest; 2019 Jan; 155(1):44-52. PubMed ID: 30056040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extent of surgery and survival in early lung carcinoma: implications for overdiagnosis in stage IA nonsmall cell lung carcinoma.
    Sugarbaker DJ; Strauss GM
    Cancer; 2000 Dec; 89(11 Suppl):2432-7. PubMed ID: 11147621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Results of surgical treatment in patients with stage IIIA non-small-cell lung cancer.
    Watanabe Y; Shimizu J; Oda M; Hayashi Y; Watanabe S; Iwa T
    Thorac Cardiovasc Surg; 1991 Feb; 39(1):44-9. PubMed ID: 1849324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnosis and surgical treatment of metastatic lung tumors].
    Yamamoto Y; Hirata T; Fukuse T; Yokomise H; Ike O; Mizuno H; Wada H; Hitomi S; Nakamura T; Shimizu Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1248-54. PubMed ID: 8831735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
    Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 53. Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma.
    Ruffini E; Parola A; Papalia E; Filosso PL; Mancuso M; Oliaro A; Actis-Dato G; Maggi G
    Eur J Cardiothorac Surg; 2001 Jul; 20(1):30-6, discussion 36-7. PubMed ID: 11423270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical treatment of IIIb-T4 lung cancer invading left atrium and great vessels.
    Wang XX; Liu TL; Yin XR
    Chin Med J (Engl); 2010 Feb; 123(3):265-8. PubMed ID: 20193242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.
    Hamaji M; Allen MS; Cassivi SD; Deschamps C; Nichols FC; Wigle DA; Shen KR
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):683-90; discussion 690-1. PubMed ID: 23414986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Operative results of non-small cell lung cancer clinically presenting mediastinal lymph adenopathy.
    Yoshino I; Yamaguchi M; Yohena T; Kameyama T; Kometani T; Osoegawa A; Maehara Y
    Fukuoka Igaku Zasshi; 2003 Aug; 94(8):250-8. PubMed ID: 14579727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer.
    Dillman RO; Zusman DR; McClure SE
    Clin Lung Cancer; 2009 Mar; 10(2):130-4. PubMed ID: 19362957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor.
    Lin BR; Chang TC; Lee YC; Lee PH; Chang KJ; Liang JT
    Ann Surg Oncol; 2009 Apr; 16(4):1026-32. PubMed ID: 19184237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†.
    Guerrera F; Errico L; Evangelista A; Filosso PL; Ruffini E; Lisi E; Bora G; Asteggiano E; Olivetti S; Lausi P; Ardissone F; Oliaro A
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):1037-43. PubMed ID: 25391390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. VATS is an adequate oncological operation for stage I non-small cell lung cancer.
    Thomas P; Doddoli C; Yena S; Thirion X; Sebag F; Fuentes P; Giudicelli R
    Eur J Cardiothorac Surg; 2002 Jun; 21(6):1094-9. PubMed ID: 12048091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.